Efficacy and safety of colchicine in inflammatory skin diseases: a retrospective, monocentric study in a large tertiary center

References

• Graham W, Roberts JB. Intravenous colchicine in the management of gouty arthritis. Ann Rheum Dis. 1953;12(1):16–19.
   PubMed Web of Science ®Google Scholar
• Malkinson FD. Colchicine. New uses of an old, old drug. Arch Dermatol. 1982;118(7):453–457.
   PubMedGoogle Scholar
• Sullivan TP, King LE, Jr, Boyd AS. Colchicine in dermatology. J Am Acad Dermatol. 1998;39(6):993–999.
   PubMed Web of Science ®Google Scholar
• Wallace SL, Omokoku B, Ertel NH. Colchicine plasma levels. Implications as to pharmacology and mechanism of action. Am J Med. 1970;48(4):443–448.
   PubMed Web of Science ®Google Scholar
• Hunter AL, Klaassen CD. Biliary excretion of colchicine. J Pharmacol Exp Ther. 1975;192(3):605–617.
   PubMed Web of Science ®Google Scholar
• Finkelstein Y, Aks SE, Hutson JR, et al. Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol (Phila). 2010;48(5):407–414.
   PubMed Web of Science ®Google Scholar
• Margulis L. Colchicine-sensitive microtubules. Int Rev Cytol. 1973;34:333–361.
   PubMed Web of Science ®Google Scholar
• Phelps P. Polymorphonuclear leukocyte motility in vitro: IV. Colchicine inhibition of chemotactic activity formation after phagocytosis of urate crystals. Arthritis Rheum. 2008;58(2 Suppl):S25–S33.
   PubMedGoogle Scholar
• Dallaverde E, Fan PT, Chang YH. Mechanism of action of colchicine. V. Neutrophil adherence and phagocytosis in patients with acute gout treated with colchicine. J Pharmacol Exp Ther. 1982;223(1):197–202.
   PubMed Web of Science ®Google Scholar
• Fitzgerald PH, Brehaut LA. Depression of DNA synthesis and mitotic index by colchicine in cultured human lymphocytes. Exp Cell Res. 1970;59(1):27–31.
   PubMed Web of Science ®Google Scholar
• Hell E, Cox DG. Effects of colchicine and colchemid on synthesis of deoxyribonucleic acid in the skin of the guinea pig's ear in vitro. Nature. 1963;197(4864):287–288.
   PubMedGoogle Scholar
• Dalbeth N, Lauterio TJ, Wolfe HR. Mechanism of action of colchicine in the treatment of gout. Clin Ther. 2014;36(10):1465–1479.
   PubMed Web of Science ®Google Scholar
• Kwon OC, Hong S, Ghang B, et al. Risk of colchicine-associated myopathy in gout: influence of concomitant use of statin. Am J Med. 2017;130(5):583–587.
   PubMed Web of Science ®Google Scholar
• Lennerz C, Barman M, Tantawy M, et al. Colchicine for primary prevention of atrial fibrillation after open-heart surgery: systematic review and meta-analysis. Int J Cardiol. 2017;249:127–137.
   PubMed Web of Science ®Google Scholar
• Imazio M. Colchicine for pericarditis. Trends Cardiovasc Med. 2015;25(2):129–136.
   PubMed Web of Science ®Google Scholar
• Chhabra L, Spodick DH. Colchicine for pericarditis. Am J Health Syst Pharm. 2014;71(23):2012–2013.
   PubMed Web of Science ®Google Scholar
• Ozer I, Mete T, Turkeli Sezer O, et al. Association between colchicine resistance and vitamin D in familial Mediterranean fever. Ren Fail. 2015;37(7):1122–1125.
   PubMed Web of Science ®Google Scholar
• Cocchi E, Chiale F, Gianoglio B, et al. Colchicine: an impressive effect on posttransplant capillary leak syndrome and renal failure. Pediatrics. 2019;143(5):e20182820.
   PubMed Web of Science ®Google Scholar
• Khandkar C, Vaidya K, Patel S. Colchicine for stroke prevention: a systematic review and meta-analysis. Clin Ther. 2019;41(3):582–590.e3.
   PubMed Web of Science ®Google Scholar
• Nidorf SM, Thompson PL. Why colchicine should be considered for secondary prevention of atherosclerosis: an overview. Clin Ther. 2019;41(1):41–48.
   PubMed Web of Science ®Google Scholar
• Tsivgoulis G, Katsanos AH, Giannopoulos G, et al. The role of colchicine in the prevention of cerebrovascular ischemia. Curr Pharm Des. 2018;24(6):668–674.
   PubMed Web of Science ®Google Scholar
• Aral CA, Aral K, Yay A, et al. Effects of colchicine on gingival inflammation, apoptosis, and alveolar bone loss in experimental periodontitis. J Periodontol. 2018;89(5):577–585.
   PubMed Web of Science ®Google Scholar
• Portincasa P. Colchicine, biologic agents and more for the treatment of familial mediterranean fever. The old, the new, and the rare. Curr Med Chem. 2015;23(1):60–86.
   Web of Science ®Google Scholar
• Puzas ÁI, Álvarez LM, Menéndez ÁF, et al. Wells' syndrome successfully treated with colchicine. Case Rep Dermatol. 2017;9(2):65–69.
   PubMed Web of Science ®Google Scholar
• Cavalcante MLLL, Masuda PY, Brito F. F D, et al. Schamberg's disease: case report with therapeutic success by using colchicine. An Bras Dermatol. 2017;92(2):246–248.
   PubMed Web of Science ®Google Scholar
• Kim M, Jain S, Harris AG, et al. Colchicine may assist in reducing granulation tissue in junctional epidermolysis bullosa. Int J Womens Dermatol. 2016;2(2):56–59.
   PubMedGoogle Scholar
• Adachi A, Komine M, Suzuki M, et al. Oral colchicine monotherapy for epidermolysis bullosa acquisita: mechanism of action and efficacy. J Dermatol. 2016;43(11):1389–1391.
   PubMed Web of Science ®Google Scholar
• Armyra K, Kouris A, Markantoni V, et al. Hidradenitis suppurativa treated with tetracycline in combination with colchicine: a prospective series of 20 patients. Int J Dermatol. 2017;56(3):346–350.
   PubMed Web of Science ®Google Scholar
• Cozzani E, Gariazzo L, Cioni M, et al. Could colchicine represent a new therapeutic approach for lichen planus pigmentosus? Dermatol Ther. 2019;32(2):e12809.
   PubMed Web of Science ®Google Scholar
• Cocco G, Chu DC, Pandolfi S. Colchicine in clinical medicine. A guide for internists. Eur J Intern Med. 2010;21(6):503–508.
   PubMed Web of Science ®Google Scholar
• Puechal X, et al. Relapsing polychondritis. Joint Bone Spine. 2014;81(2):118–124.
   PubMed Web of Science ®Google Scholar
• Robinson KP, Chan JJ. Colchicine in dermatology: a review. Australas J Dermatol. 2018;59(4):278–285.
   PubMed Web of Science ®Google Scholar
• Callen JP. Colchicine is effective in controlling chronic cutaneous leukocytoclastic vasculitis. J Am Acad Dermatol. 1985;13(2):193–200.
   PubMed Web of Science ®Google Scholar
• Hazen PG, Michel B. Management of necrotizing vasculitis with colchicine. Improvement in patients with cutaneous lesions and Behcet's syndrome. Arch Dermatol. 1979;115(11):1303–1306.
   PubMedGoogle Scholar
• Jachiet M, Flageul B, Deroux A, et al. The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: data from a French nationwide study of fifty-seven patients. Arthritis Rheumatol. 2015;67(2):527–534.
   PubMed Web of Science ®Google Scholar
• Sais G, Vidaller A, Jucglà A, et al. Colchicine in the treatment of cutaneous leukocytoclastic vasculitis. Results of a prospective, randomized controlled trial. Arch Dermatol. 1995;131(12):1399–1402.
   PubMedGoogle Scholar
• Katz J, Langevitz P, Shemer J, et al. Prevention of recurrent aphthous stomatitis with colchicine: an open trial. J Am Acad Dermatol. 1994;31(3):459–461.
   PubMed Web of Science ®Google Scholar
• Ruah CB, Stram JR, Chasin WD. Treatment of severe recurrent aphthous stomatitis with colchicine. Arch Otolaryngol Head Neck Surg. 1988;114(6):671–675.
   PubMedGoogle Scholar
• Yurdakul S, Mat C, Tüzün Y, et al. A double-blind trial of colchicine in Behcet's syndrome. Arthritis Rheum. 2001;44(11):2686–2692.
   PubMed Web of Science ®Google Scholar
• Aktulga E, Altaç M, Müftüoglu A, et al. A double blind study of colchicine in Behcet's disease. Haematologica. 1980;65(3):399–402.
   PubMed Web of Science ®Google Scholar
• Masuda K, et al. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behcet's disease. Lancet. 1989;1(8647):1093–1096.
   PubMed Web of Science ®Google Scholar
• Wechsler B. [Colchicine and Behcet's disease: an efficacious treatment finally recognized!]. Rev Med Interne. 2002;23(4):355–356.
   PubMed Web of Science ®Google Scholar
• Ahern MJ, Reid C, Gordon TP, et al. Does colchicine work? The results of the first controlled study in acute gout. Aust NZ J Med. 1987;17(3):301–304.
   PubMedGoogle Scholar
• Abbott CE, Xu R, Sigal SH. Colchicine-induced hepatotoxicity. ACG Case Rep J. 2017;4(1):e120.
   PubMed Web of Science ®Google Scholar
• Arslan MN, Özgün A, Daş T, et al. Colchicine-induced rhabdomyolysis: an autopsy case. Am J Forensic Med Pathol. 2016;37(2):57–59.
   PubMed Web of Science ®Google Scholar
• Olmos-Martinez JM, et al. Acute colchicine-induced neuromyopathy in a patient treated with atorvastatin and clarithromycin. Eur J Case Rep Intern Med. 2019;6(3):001066.
   PubMedGoogle Scholar
• Hirayama I, Hiruma T, Ueda Y, et al. A critically ill patient after a colchicine overdose below the lethal dose: a case report. J Med Case Rep. 2018;12(1):191.
   PubMedGoogle Scholar
• Merlin HE. Azoospermia caused by colchicine–a case report. Fertil Steril. 1972;23(3):180–181.
   PubMed Web of Science ®Google Scholar
• Ehrenfeld M, A B, Levy M, et al. Colchicine: infertility incidence study. Br J Obstet Gynaecol. 1987;94(12):1186–1191.
   PubMedGoogle Scholar
• Katsilambros Y. Colchicine in the preventive treatment of rubella embryopathy. Arch Inst Pasteur Hellen. 1963;9:97–99.
   Google Scholar
• Rabinovitch O, Zemer D, Kukia E, et al. Colchicine treatment in conception and pregnancy: two hundred thirty-one pregnancies in patients with familial Mediterranean fever. Am J Reprod Immunol. 1992;28(3–4):245–246.
   PubMed Web of Science ®Google Scholar
• An Cestari JVF, Yonenago Y. A case of human reproductive abnormalities possibly induced by colchicine treatment. Rev Brazil Biol. 1965;25:253–256.
   Google Scholar
• Morris I, Varughese G, Mattingly P. Colchicine in acute gout. BMJ. 2003;327(7426):1275–1276.
   PubMed Web of Science ®Google Scholar